2IIV image
Deposition Date 2006-09-28
Release Date 2006-11-28
Last Version Date 2024-10-30
Entry Detail
PDB ID:
2IIV
Keywords:
Title:
Human dipeptidyl peptidase 4 in complex with a diazepan-2-one inhibitor
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.15 Å
R-Value Free:
0.22
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Dipeptidyl peptidase 4 soluble form
Gene (Uniprot):DPP4
Mutations:Ser39Thr
Chain IDs:A, B
Chain Length:728
Number of Molecules:2
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
ASN A ASN GLYCOSYLATION SITE
Primary Citation
(3R)-4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one, a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
Bioorg.Med.Chem.Lett. 17 49 52 (2007)
PMID: 17055272 DOI: 10.1016/j.bmcl.2006.09.099

Abstact

Replacement of the triazolopiperazine ring of sitagliptin (DPP-4 IC(50)=18nM) with 3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one gave dipeptidyl peptidase IV (DPP-4) inhibitor 1 which is potent (DPP-4 IC(50)=2.6nM), selective, and efficacious in an oral glucose tolerance test in mice. It was selected for extensive preclinical development as a potential back-up candidate to sitagliptin.

Legend

Protein

Chemical

Disease

Primary Citation of related structures